In the spotlight

Glanzmann Disease Working Group

The EAHAD Glanzmann Disease Working Group was formed in December 2022. Its purpose and goals are:

  •  Improvement of care for patients with Glanzmann Disease
  • Sharing and dissemination of knowledge among European health care practitioners regarding the treatment of patients with Glanzmann Disease
  • Definition and execution of a pan-European research agenda on the topic of Glanzmann Disease
  • Creation of a European network that is tightly connected and easily accessible to improve care for patients with Glanzmann Disease, with the objective of interacting on patient care and coordinate clinical research

The members of the working group are:

Dr Roger Schutgens

Chair

The Netherlands

Dr Roseline d’Oiron

Haematologist

France

Dr Mathieu Fiore

Haematologist

France

Dr Robert Klamroth

Haematologist

Germany

Dr Andrea Artoni

Haematologist

Italy

Dr Mary Mathias

Haematologist

United Kingdom

Minette van der Ven

Vice-President Finance

The Netherlands

Suthesh Sivapalaratnam

Haematologist

The Netherlands

Giancarlo Castaman

Haematologist

Italy

Wolfgang Miesbach

Haematologist

Germany